— Main Menu —
ABOUT
LOCATIONS
Study Results
Results Resources
Study Team
NEWS
ABOUT
LOCATIONS
Study Results
Results Resources
Study Team
NEWS
A4 Study Results: Investigational Anti-Amyloid Treatment Started Before Alzheimer’s Symptoms Did Not Slow Memory Loss
March 09, 2023
Nick
Off
Brigham & Women’s Hospital
READ MORE
Lilly Provides Update on A4 Study of Solanezumab for Preclinical Alzheimer’s Disease
March 08, 2023
Nick
Off
Eli Lilly & Company
READ MORE
Predicting Amyloid Positivity in Cognitively Unimpaired Older Adults: A Machine Learning Approach Using A4 Data
June 14, 2022
Nick
Off
Petersen KK, Lipton RB, Grober E, Davatzikos C, Sperling RA, Ezzati A. Neurology. 2022;98(24):e2425-e2435.
READ MORE
Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease
June 01, 2022
Nick
Off
Young CB, Winer JR, Younes K, et al. JAMA neurology; JAMA Neurol. 2022;79(6):592-603.
READ MORE
Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI:The A4 Study
March 29, 2022
Nick
Off
Grober E, Lipton RB, Sperling RA, et al. Neurology. 2022;98(13):e1327-e1336.
READ MORE
Analyzing the future time perspective scale in the baseline period in the Anti-Amyloid treatment in Asymptomatic Alzheimer’s Disease (A4) Study
December 31, 2021
Nick
Off
Stites SD, Dedhia M, Grill JD, Karlawish J. Alzheimer’s & dementia. 2021;17:n/a.
READ MORE
Brain amyloid burden, sleep, and 24-hour rest/activity rhythms: Screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration Studies
September 19, 2021
Nick
Off
Spira AP, Zipunnikov V, Raman R, et al. Sleep Adv. 2021; 2(1): zpab015.
READ MORE
Association of short and long sleep duration with amyloid-beta burden and cognition in aging
August 30, 2021
Nick
Off
Joseph R Winer 1 , Kacie D Deters 1 , Gabriel Kennedy 1 , Meghan Jin 1 , Andrea Goldstein-Piekarski 2 3 , Kathleen L Poston 1 , Elizabeth C Mormino 1. JAMA Neurol. 2021 Oct; 78(10): 1–10.
READ MORE
Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) trial
August 17, 2021
Nick
Off
Ngolab J, Donohue M, Belsha A, et al. Alzheimer’s & dementia: diagnosis, assessment & disease monitoring; Alzheimers Dement (Amst). 2021;13(1):e12199-n/a.
READ MORE
Feasibility Study Conducted for A4 Trial
August 17, 2021
Nick
Off
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
READ MORE
1
2
3
Your upload was successful!